BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,614,277 | -13.0% | 201,676 | +4.9% | 0.02% | -10.7% |
| Q2 2023 | $8,756,947 | +16.4% | 192,228 | +3.6% | 0.03% | -6.7% |
| Q1 2023 | $7,525,989 | -21.3% | 185,552 | -1.1% | 0.03% | -30.2% |
| Q4 2022 | $9,568,262 | +1.3% | 187,705 | +7.2% | 0.04% | -10.4% |
| Q3 2022 | $9,442,000 | -17.5% | 175,050 | -1.8% | 0.05% | -9.4% |
| Q2 2022 | $11,449,000 | -17.2% | 178,234 | 0.0% | 0.05% | -1.9% |
| Q1 2022 | $13,821,000 | -5.5% | 178,234 | +4.6% | 0.05% | 0.0% |
| Q4 2021 | $14,630,000 | +1.5% | 170,441 | -4.9% | 0.05% | -6.9% |
| Q3 2021 | $14,408,000 | -3.6% | 179,180 | -3.5% | 0.06% | -4.9% |
| Q2 2021 | $14,940,000 | -5.2% | 185,604 | -0.7% | 0.06% | -15.3% |
| Q1 2021 | $15,761,000 | +9.1% | 186,852 | +3.8% | 0.07% | -5.3% |
| Q4 2020 | $14,441,000 | -1.4% | 180,053 | -2.8% | 0.08% | -14.6% |
| Q3 2020 | $14,653,000 | -6.1% | 185,292 | 0.0% | 0.09% | -18.3% |
| Q2 2020 | $15,606,000 | -0.5% | 185,292 | -3.0% | 0.11% | -14.2% |
| Q1 2020 | $15,679,000 | -1.8% | 191,037 | -0.2% | 0.13% | +14.4% |
| Q4 2019 | $15,966,000 | -4.9% | 191,329 | -0.4% | 0.11% | -12.6% |
| Q3 2019 | $16,789,000 | +2.9% | 192,040 | -4.3% | 0.13% | -0.8% |
| Q1 2019 | $16,318,000 | +17.0% | 200,621 | -6.2% | 0.13% | +4.9% |
| Q4 2018 | $13,951,000 | -9.8% | 213,940 | +2.1% | 0.12% | -21.8% |
| Q2 2018 | $15,475,000 | +88.7% | 209,591 | +15.6% | 0.16% | +16.4% |
| Q2 2016 | $8,201,000 | +6112.9% | 181,375 | -96.7% | 0.13% | -29.1% |
| Q1 2016 | $132,000 | -98.2% | 5,436,745 | +2685.5% | 0.19% | +64.3% |
| Q4 2015 | $7,424,000 | +15.4% | 195,181 | -0.3% | 0.12% | +10.6% |
| Q3 2015 | $6,432,000 | -45.0% | 195,784 | +24.8% | 0.10% | -61.2% |
| Q2 2014 | $11,688,000 | -1.9% | 156,927 | -0.7% | 0.27% | -3.2% |
| Q1 2014 | $11,916,000 | +31.9% | 158,096 | +22.5% | 0.28% | +21.0% |
| Q4 2013 | $9,037,000 | +8.2% | 129,085 | +1.2% | 0.23% | +2.2% |
| Q3 2013 | $8,350,000 | -5.2% | 127,595 | +0.9% | 0.22% | -12.8% |
| Q2 2013 | $8,810,000 | – | 126,404 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |